We are live on ! Find out more
CAL

Capital Analysts LLC Portfolio holdings

AUM $4.34B
1-Year Est. Return 17.55%
This Fund
S&P 500
This Quarter Est. Return
-0.41%
1 Year Est. Return
+17.55%
3 Year Est. Return
+51.26%
5 Year Est. Return
+53.67%
10 Year Est. Return
+184.17%
AUM
$2.68B
AUM Growth
+$190M
Cap. Flow
+$224M
Cap. Flow %
8.36%
Top 10 Hldgs %
33.25%
Holding
1,438
New
142
Increased
550
Reduced
287
Closed
78
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOX icon
976
Vanguard Communication Services ETF
VOX
$5.85B
$22K ﹤0.01%
149
HIMU
977
iShares High Yield Muni Active ETF
HIMU
$2.44B
$22K ﹤0.01%
+438
New +$21.9K
BIPC icon
978
Brookfield Infrastructure
BIPC
$4.85B
$21K ﹤0.01%
588
BNS icon
979
Scotiabank
BNS
$108B
$21K ﹤0.01%
442
+6
+1% +$301
BR icon
980
Broadridge
BR
$19B
$21K ﹤0.01%
88
EMBC icon
981
Embecta
EMBC
$262M
$21K ﹤0.01%
1,672
-81
-5% -$1.3K
EOS
982
Eaton Vance Enhance Equity Income Fund II
EOS
$1.18B
$21K ﹤0.01%
994
-106
-10% -$2.47K
FEM icon
983
First Trust Emerging Markets AlphaDEX Fund
FEM
$786M
$21K ﹤0.01%
+935
New +$21.1K
FFEB icon
984
FT Vest US Equity Buffer ETF February
FFEB
$1.41B
$21K ﹤0.01%
421
ING icon
985
ING
ING
$102B
$21K ﹤0.01%
1,049
IPG
986
DELISTED
Interpublic Group of Companies
IPG
$21K ﹤0.01%
767
+1
+0.1% +$27
LIT icon
987
Global X Lithium & Battery Tech ETF
LIT
$1.59B
$21K ﹤0.01%
536
-349
-39% -$14.3K
NOW icon
988
ServiceNow
NOW
$129B
$21K ﹤0.01%
130
-70
-35% -$13.5K
PPH icon
989
VanEck Pharmaceutical ETF
PPH
$988M
$21K ﹤0.01%
232
RCL icon
990
Royal Caribbean
RCL
$85.6B
$21K ﹤0.01%
100
WES icon
991
Western Midstream Partners
WES
$19.3B
$21K ﹤0.01%
+517
New +$21.1K
CRON
992
Cronos Group
CRON
$1.14B
$20K ﹤0.01%
11,100
FSEP icon
993
FT Vest US Equity Buffer ETF September
FSEP
$1.25B
$20K ﹤0.01%
460
IXN icon
994
iShares Global Tech ETF
IXN
$9.26B
$20K ﹤0.01%
259
FDIQ
995
Invesco Bloomberg Financial Data Providers ETF
FDIQ
$48.4M
$20K ﹤0.01%
+364
New +$21.8K
MOO icon
996
VanEck Agribusiness ETF
MOO
$973M
$20K ﹤0.01%
298
NXTG icon
997
First Trust Indxx NextG ETF
NXTG
$564M
$20K ﹤0.01%
+236
New +$20.6K
PGX icon
998
Invesco Preferred ETF
PGX
$3.78B
$20K ﹤0.01%
1,756
PPL
999
PPL Corp
PPL
$26.7B
$20K ﹤0.01%
+554
New +$18.8K
RDIV icon
1000
Invesco S&P Ultra Dividend Revenue ETF
RDIV
$1.39B
$20K ﹤0.01%
404

Similar funds

Capital Analysts LLC's Q1 2025 Portfolio in Review

As of Q1 2025, Capital Analysts LLC held 1,438 positions worth $2.68B, up 7.6% from $2.49B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Capital Analysts LLC deployed $224M of net new capital in Q1 2025, opening 142 new positions and adding to 550 existing holdings. Its largest new stake was ALPS O'Shares US Small-Cap Quality Dividend ETF: 836,574 shares worth $35.2M.

By sector, the portfolio is most concentrated in Technology at 7.3% of assets, down from 8.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Core S&P Mid-Cap ETF, an estimated $56.5M trimmed.

  • Capital Analysts LLC's largest Q1 2025 buy was ALPS O'Shares US Small-Cap Quality Dividend ETF: 836,574 shares worth $35.2M.
  • Capital Analysts LLC added most to Fidelity Enhanced Mid Cap Core ETF in Q1 2025, an estimated $62.4M increase.
  • Capital Analysts LLC's biggest Q1 2025 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $56.5M.
  • Capital Analysts LLC fully exited West Pharmaceutical in Q1 2025, selling an estimated $642K.
  • Capital Analysts LLC's ten largest holdings make up 33% of its $2.68B portfolio in Q1 2025.
  • Capital Analysts LLC opened 142 new positions and closed 78 in Q1 2025.
  • Capital Analysts LLC's portfolio value rose 7.6% quarter-over-quarter to $2.68B.

Based on Capital Analysts LLC's 13F filing for Q1 2025, filed 14 May 2025.